167 related articles for article (PubMed ID: 38771392)
1. Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2
Lazovic B; Nguyen HT; Ansarizadeh M; Wigge L; Kohl F; Li S; Carracedo M; Kettunen J; Krimpenfort L; Elgendy R; Richter K; De Silva L; Bilican B; Singh P; Saxena P; Hong X; Eklund L; Hicks R
Angiogenesis; 2024 May; ():. PubMed ID: 38771392
[TBL] [Abstract][Full Text] [Related]
2. Ponatinib Combined With Rapamycin Causes Regression of Murine Venous Malformation.
Li X; Cai Y; Goines J; Pastura P; Brichta L; Lane A; Le Cras TD; Boscolo E
Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):496-512. PubMed ID: 30626204
[TBL] [Abstract][Full Text] [Related]
3. AKT/FOXO1 axis links cross-talking of endothelial cell and pericyte in TIE2-mutated venous malformations.
Si Y; Huang J; Li X; Fu Y; Xu R; Du Y; Cheng J; Jiang H
Cell Commun Signal; 2020 Aug; 18(1):139. PubMed ID: 32867785
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.
Boscolo E; Limaye N; Huang L; Kang KT; Soblet J; Uebelhoer M; Mendola A; Natynki M; Seront E; Dupont S; Hammer J; Legrand C; Brugnara C; Eklund L; Vikkula M; Bischoff J; Boon LM
J Clin Invest; 2015 Sep; 125(9):3491-504. PubMed ID: 26258417
[TBL] [Abstract][Full Text] [Related]
5. Variable Somatic TIE2 Mutations in Half of Sporadic Venous Malformations.
Soblet J; Limaye N; Uebelhoer M; Boon LM; Vikkula M
Mol Syndromol; 2013 Apr; 4(4):179-83. PubMed ID: 23801934
[TBL] [Abstract][Full Text] [Related]
6. Constitutive Active Mutant TIE2 Induces Enlarged Vascular Lumen Formation with Loss of Apico-basal Polarity and Pericyte Recruitment.
Cai Y; Schrenk S; Goines J; Davis GE; Boscolo E
Sci Rep; 2019 Aug; 9(1):12352. PubMed ID: 31451744
[TBL] [Abstract][Full Text] [Related]
7. Review of the endothelial pathogenic mechanism of TIE2-related venous malformation.
Du Z; Zheng J; Zhang Z; Wang Y
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):740-748. PubMed ID: 28818232
[TBL] [Abstract][Full Text] [Related]
8. Classification and Tie2 mutations in spinal and soft tissue vascular anomalies.
Zhou M; Jiang R; Zhao G; Wang L; Wang H; Li W; Li Y; Du X; Bai J
Gene; 2015 Oct; 571(1):91-6. PubMed ID: 26115772
[TBL] [Abstract][Full Text] [Related]
9. Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB.
Uebelhoer M; Nätynki M; Kangas J; Mendola A; Nguyen HL; Soblet J; Godfraind C; Boon LM; Eklund L; Limaye N; Vikkula M
Hum Mol Genet; 2013 Sep; 22(17):3438-48. PubMed ID: 23633549
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations.
Limaye N; Wouters V; Uebelhoer M; Tuominen M; Wirkkala R; Mulliken JB; Eklund L; Boon LM; Vikkula M
Nat Genet; 2009 Jan; 41(1):118-24. PubMed ID: 19079259
[TBL] [Abstract][Full Text] [Related]
11. Direct conversion of adult skin fibroblasts to endothelial cells by defined factors.
Han JK; Chang SH; Cho HJ; Choi SB; Ahn HS; Lee J; Jeong H; Youn SW; Lee HJ; Kwon YW; Cho HJ; Oh BH; Oettgen P; Park YB; Kim HS
Circulation; 2014 Sep; 130(14):1168-78. PubMed ID: 25186941
[TBL] [Abstract][Full Text] [Related]
12. Proteomics of novel induced pluripotent stem cell-derived vascular endothelial cells reveal extensive similarity with an immortalized human endothelial cell line.
Ariyasinghe NR; de Souza Santos R; Gross A; Aghamaleky-Sarvestany A; Kreimer S; Escopete S; Parker SJ; Sareen D
Physiol Genomics; 2023 Aug; 55(8):324-337. PubMed ID: 37306406
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the pro-angiogenic potential of human induced pluripotent stem cell derived endothelial cells and induced endothelial cells in a murine model of peripheral arterial disease.
Clayton ZE; Yuen GS; Sadeghipour S; Hywood JD; Wong JW; Huang NF; Ng MK; Cooke JP; Patel S
Int J Cardiol; 2017 May; 234():81-89. PubMed ID: 28209385
[TBL] [Abstract][Full Text] [Related]
14. A xenograft model for venous malformation.
Goines J; Li X; Cai Y; Mobberley-Schuman P; Metcalf M; Fishman SJ; Adams DM; Hammill AM; Boscolo E
Angiogenesis; 2018 Nov; 21(4):725-735. PubMed ID: 29786783
[TBL] [Abstract][Full Text] [Related]
15. A Xenograft Model for Venous Malformation.
Goines J; Boscolo E
Methods Mol Biol; 2021; 2206():179-192. PubMed ID: 32754818
[TBL] [Abstract][Full Text] [Related]
16. Supporting materials: Endothelial cells differentiated from patient dermal fibroblast-derived induced pluripotent stem cells resemble vascular malformations of Port Wine Birthmark.
Nguyen V; Gao C; Hochman ML; Kravitz J; Chen EH; Friedman HI; Wenceslau CF; Chen D; Wang Y; Nelson JS; Jegga AG; Tan W
bioRxiv; 2023 Aug; ():. PubMed ID: 37662218
[TBL] [Abstract][Full Text] [Related]
17. Exposure of Induced Pluripotent Stem Cell-Derived Vascular Endothelial and Smooth Muscle Cells in Coculture to Hemodynamics Induces Primary Vascular Cell-Like Phenotypes.
Collado MS; Cole BK; Figler RA; Lawson M; Manka D; Simmers MB; Hoang S; Serrano F; Blackman BR; Sinha S; Wamhoff BR
Stem Cells Transl Med; 2017 Aug; 6(8):1673-1683. PubMed ID: 28628273
[TBL] [Abstract][Full Text] [Related]
18. STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.
Huang YH; Wu MP; Pan SC; Su WC; Chen YW; Wu LW
Angiogenesis; 2013 Jan; 16(1):207-22. PubMed ID: 23086340
[TBL] [Abstract][Full Text] [Related]
19. Role of UDP-glucose ceramide glucosyltransferase in venous malformation.
Chen S; Wang Y; Kong L; Ji Y; Cui J; Shen W
Front Cell Dev Biol; 2023; 11():1178045. PubMed ID: 37274734
[TBL] [Abstract][Full Text] [Related]
20. Common and specific effects of TIE2 mutations causing venous malformations.
Nätynki M; Kangas J; Miinalainen I; Sormunen R; Pietilä R; Soblet J; Boon LM; Vikkula M; Limaye N; Eklund L
Hum Mol Genet; 2015 Nov; 24(22):6374-89. PubMed ID: 26319232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
